홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
Heatmap
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
한국어
English
Русский
中文
Español
Português
日本語
Deutsch
Français
Italiano
Türkçe
NRIX
#2090
Nurix Therapeutics, Inc. Common stock
16.450
0
USD
+3.39%
부문:
헬스케어
베이스:
USD
수익 통화:
USD
일일 변동 비율
년간 변동
일일 변동
+3.39%
월간 변동
+7.24%
6달 변화
+46.74%
년간 변동율
+46.74%
이전 종가
15.910
0
Open
16.470
0
Bid
Ask
Low
16.450
0
High
16.490
0
양
13
마켓
주식
헬스케어
NRIX
Open full chart
Financials
Overview
성명
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
38.91 M
44.74 M
47.27 M
48.89 M
75.89 M
102.84 M
—
Valuation ratios
Enterprise value
1.54 B
1.21 B
521.24 M
249.49 M
1.52 B
1.49 B
4.52 B
Price to earnings ratio
—
—
-3.34
-2.35
-7.46
-5.54
-18.28
Price to sales ratio
—
—
15.59
4.39
26.44
17.45
—
Price to cash flow ratio
—
—
-3.77
-4.15
-8.36
-5.87
-23.48
Price to book ratio
—
—
1.98
1.69
2.74
2.72
4.39
EBITDA 비율에 대한 기업 가치
-23.78
-10.4
-2.84
-1.55
-6.78
-5.04
—
Profitability ratios
Return on assets %
-0.11
-0.25
-0.43
-0.4
-0.29
-0.38
-0.22
Return on equity %
-0.15
-0.34
-0.59
-0.72
-0.37
-0.49
-0.29
Return on invested capital %
-132.86
-271.17
-403.07
-279.55
-715.83
-928.38
-408.18
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-364.66
-396.26
-476.01
-201.41
-390.52
-340.16
-399.92
EBITDA margin %
-363.13
-390.52
-474.9
-208.46
-411.22
-352.45
-3 438.16
Net margin %
-242.66
-393.93
-466.93
-186.98
-354.85
-314.9
-375.22
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
6.7
4.7
4.51
3.4
6.46
7.02
25.2
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.04
0.07
0.09
0.2
0.11
0.12
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-3.29
-1.5
-2.57
-2.88
-1.56
EBIT per share
—
—
-3.78
-2.85
-3.17
-3.3
-3.46
EBITDA per share
—
—
-3.77
-2.95
-3.34
-3.42
-3.56
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
6.36
5.3
9.08
6.84
22.64
Net current asset value per share
—
—
6.55
5.44
9.23
7
23.42
Tangible book value per share
—
—
6.25
3.69
7.85
6.22
20.34
Working capital per share
—
—
5.1
3.84
7.8
6
19.7
Book value per share
—
—
6.25
3.69
7.85
6.22
20.34
뉴스
Does Nurix Therapeutics (NRIX) Have the Potential to Rally 85.84% as Wall Street Analysts Expect?
Company News for Apr 9, 2026
Nurix Therapeutics, Inc. (NRIX) Reports Q1 Loss, Lags Revenue Estimates
Nurix Therapeutics (NRIX) Moves 6.9% Higher: Will This Strength Last?
Precigen, Inc. (PGEN) Reports Q4 Loss, Lags Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
Nurix Therapeutics amends equity distribution agreement for $413.65 million stock offering
캐시 우드의 ARK, 로쿠 매도, 알리바바와 바이오엔테크 매수
Nurix (NRIX) 법률 책임자, 125,792달러 상당 주식 매도
Ring, chief legal officer, sells Nurix (NRIX) shares for $125,792
Nurix Therapeutics Stock Sees RS Rating Jump To 82
Nurix 법률 책임자, NRIX 주식 23만 7천 달러 매도